Hualan Biological Vaccine Inc.
华兰疫苗
301207
Shenzhen Stock Exchange
Company Profile
Hualan Biological Bacterin Inc. is engaged in the research and development, production and sales of vaccines. Currently,Hualan has developed more than 10 kinds of products involving 3 major fields: viral vaccines, bacterial vaccines and genetically engineered vaccines. Hualan owns vaccine industrialization platforms and an emer gency research and development system enabling the quick and effective development and mass production of the vaccine against emerging infectious diseases. Hualan Bacterin currently has six production lines of influenza vaccine bulk and eight filling lines of influenz a vaccine. It can produce 400 million person doses of single-dose influenza vaccine and 100 million doses of quadrivalent influenza vaccine per year. Hualan biological influenza vaccine production capacity is the third in the world, and will play a critical role in the prevention of influenza epidemic in China and the world. The rapid and sustainable development of Hualan Vaccine relies on strong investment in scientific research. Hualan Vaccine spends 5-10%of its annual sales revenue on research and development of new products. The company has always adhered to independent research and development and the combination of industry-university-research. With the implementation of major national, provincial and municipal projects as the main focus, the company has broken through a number of key core technologies. The company has built core technology platforms such as "influenza virus vaccine research and development and large-scale production Technology Platform", "multi-conjugate and multivalent vaccine technology platform", "genetic engineering vaccine technology platform", "large-scale culture of mammalian cells and universal vaccine preparation technology platform", and promoted the company's core vaccine technology breakthrough and key process research, and promoted the transformation of major scientific and technological achievements. The company undertook 9 national major projects, including "Influenza virus vaccine emergency research and development system capacity building and product development", "Vaccine International Certification Construction Project", "Development and application of efficient separation and purification media". Relying on the advantages of the company's research and development technology platform, we constantly improve and optimize the production and preparation process, realize pipelining, automation and scale production process, and strictly control the purity, safety and titer of products in scale production, to ensure the safety and efficiency of products.
Full description
Hualan Biological Bacterin Inc., founded in 2005, is a high-tech enterprise engaged in the R&D, production and sales of vaccine products. It is the largest influenza vaccine manufacturer in China, the birthplace of the first Influenza A (H1N1) Vaccine in the world, and the fifth in the world and the only enterprise in China that has passed the WHO pre-qualification of influenza vaccine. The Company gained the“ ISO” quality system certificate in quality, environment,occupational health and safety management. Hualan has a number of independent intellectual properties and major products. The Company is leading the domestic industrial development with advantages in production scale,market share and brand influence. Recently, Hualan influenza vaccine ranked the top in China in terms of production quantity and market share. Hualan Biological Bacterin Inc. owns 8 kinds of products including Influenza Vaccine (Split Virion), Inactivated,Influenza A (H1N1) Vaccine (Split Virion), Inactivated, Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, Group A and C Meningococcal Polysaccharide Vaccine, Group ACYW135 Meningococcal Polysaccharide Vaccine, Recombinant Hepatitis B Vaccine (Hansenula Polymorpha), Rabies Vaccine for Human Use and Tetanus Vaccine (Adsorbed). For more than 10 years, the Company has been dedicated to the biopharmaceutical field, focusing on development and striving for innovation, to constantly expand the influence and strengthen the power of Hualan. In order to break the barrier and monopoly of developed countries in the field of biological products, Hualan has overcome various difficulties and constraints to build a domestic brand. The company’s unique spirit was born from the rapid and leap-forward growth on the way of scientific development. With the quality policy of " Always pursuing a higher safety for bio-products." in mind, by adhering to the management principle of " Guarantee Credibility with Quality and Safety ", Hualan will always be committed to the career to protect the health of the common people and the safety of the national public health.